arctigenin has been researched along with Cancer of Colon in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, HR; Yoon, SB | 1 |
| Feng, D; Gu, Y; Laschke, MW; Menger, MD; Scheuer, C | 1 |
| Cha, MR; Hwang, JH; Hwang, YI; Kim, JY; Ko, B; Park, HR; Shin-ya, K; Son, ES; Song, SW; Tomida, A; Yoon, MY | 1 |
3 other study(ies) available for arctigenin and Cancer of Colon
| Article | Year |
|---|---|
Arctigenin Inhibits Etoposide Resistance in HT-29 Colon Cancer Cells during Microenvironmental Stress.
Topics: Antineoplastic Agents; Apoptosis; Cell Survival; Colonic Neoplasms; Colony-Forming Units Assay; DNA Topoisomerases, Type II; Drug Resistance, Neoplasm; Endoplasmic Reticulum Chaperone BiP; Etoposide; Furans; Heat-Shock Proteins; HT29 Cells; Humans; Lignans; Stress, Physiological; Tumor Microenvironment | 2019 |
Inhibition of angiogenesis: a novel antitumor mechanism of the herbal compound arctigenin.
Topics: Angiogenesis Inhibitors; Angiogenic Proteins; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Endothelial Cells; Furans; Humans; Immunohistochemistry; Lignans; Male; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Neovascularization, Pathologic; Neovascularization, Physiologic; Phytotherapy; Plants, Medicinal; Rats; Rats, Sprague-Dawley; Signal Transduction; Spheroids, Cellular; Time Factors; Tissue Culture Techniques; Tumor Burden | 2013 |
Arctigenin blocks the unfolded protein response and shows therapeutic antitumor activity.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Endoplasmic Reticulum Chaperone BiP; Furans; Gene Expression Regulation, Neoplastic; Glucose; HeLa Cells; HT29 Cells; Humans; Lignans; Mice; Mice, Nude; Time Factors; Tumor Burden; Unfolded Protein Response; Xenograft Model Antitumor Assays | 2010 |